People on the Move
Formycon AG
Formycon AG, a German biosimilars developer, has appointed to its advisory board Bernhard Hampl, the former CEO of several American pharmaceutical businesses.
Hampl led the generics companies EON LABS and Sandoz US before their merger. He now advises pharmaceutical and biotechnology industries.
Formycon AG is nearing the end of the preclinical stages of its first projects and looking for international co-operations, particularly in the US. The CEO, Carsten Brockmeyer, said Hampl had been recruited for his North American experience.